The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2019 | Challenges in NSCLC: acquired resistance
Laura Bonanno, MD, Veneto Institute of Oncology, Padova, Italy, explains the challenges facing patients with non-small cell lung cancer (NSCLC). Dr Bonanno explains how the use of genetic screening and immunotherapy has lead to two new challenges; understanding the mechanisms which result in resistance, and how to overcome this acquired resistance. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.
